YE
Insider
Yann Echelard
DirectorYann Echelard (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in TG Therapeutics, Inc. (TGTX). The largest single filing was $163K of TGTX (5,000 sh × $32.57, as filed), executed Nov 24 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$163K
shares × price, as filed
Last traded
Nov 24 2025
Filed Nov 25 2025
Median ADV $126.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
TGTX
TG Therapeutics, Inc.
TGTX · 0 buys · 3 sells
3 filings
Recent filings
TGTXSALE
TG Therapeutics, Inc.
View filing →
$163K5,000 sh × $32.57
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET TGTXSALE TG Therapeutics, Inc. View filing → $369K
10,000 sh × $36.94
Exec Jun 13 2025
Filed Jun 16 2025 · 5:30 PM ET TGTXSALE TG Therapeutics, Inc. View filing → $490K
20,000 sh × $24.48
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET